Literature DB >> 8094742

Adenosine A1 receptor inhibition of glutamate exocytosis and protein kinase C-mediated decoupling.

A P Barrie1, D G Nicholls.   

Abstract

The adenosine modulation of glutamate exocytosis from guinea pig cerebrocortical synaptosomes is investigated. Endogenously leaked adenosine is sufficient to cause a partial tonic inhibition of 4-aminopyridine-evoked glutamate release, which can be relieved by adenosine deaminase. The adenosine A1 receptor is equally effective in mediating inhibition of glutamate exocytosis evoked by 4-aminopyridine (where K(+)-channel activation would inhibit release) and by elevated KCl (where K(+)-channel activation would have no effect), arguing for a central role of Ca(2+)-channel modulation. In support of this, the plateau phase of depolarization-evoked free Ca2+ elevation is decreased by adenosine with both depolarization protocols. No effect of adenosine agonists is seen on membrane potential in polarized or KCl- or 4-aminopyridine-stimulated synaptosomes. The interaction of protein kinase C with the A1 receptor-mediated inhibition is examined. Activation of protein kinase C by 4 beta-phorbol dibutyrate has been shown previously by this laboratory to modulate glutamate release via K(+)-channel inhibition, and is shown here to have an additional action of decoupling the adenosine inhibition of glutamate exocytosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094742     DOI: 10.1111/j.1471-4159.1993.tb03257.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

Review 1.  The regulation of neurotransmitter secretion by protein kinase C.

Authors:  P F Vaughan; J H Walker; C Peers
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

Review 2.  Bioenergetics and transmitter release in the isolated nerve terminal.

Authors:  David G Nicholls
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

3.  Modulation of the dinucleotide receptor present in rat midbrain synaptosomes by adenosine and ATP.

Authors:  M Díaz-Hernández; J Pintor; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 4.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

5.  Role of dopamine D2-like receptors and their modulation by adenosine receptor stimulation in the reinstatement of methamphetamine seeking.

Authors:  Tracey A Larson; Madeline C Winkler; Jacob Stafford; Sophia C Levis; Casey E O'Neill; Ryan K Bachtell
Journal:  Psychopharmacology (Berl)       Date:  2018-11-23       Impact factor: 4.530

6.  Genetically controlled upregulation of adenosine A(1) receptor expression enhances the survival of primary cortical neurons.

Authors:  Tsvetan Serchov; Hasan-Cem Atas; Claus Normann; Dietrich van Calker; Knut Biber
Journal:  Mol Neurobiol       Date:  2012-08-17       Impact factor: 5.590

7.  Disruption of the ATP/adenosine balance in CD39-/- mice is associated with handling-induced seizures.

Authors:  Amanda J Lanser; Rafael M Rezende; Stephen Rubino; Paul J Lorello; Dustin J Donnelly; Huixin Xu; Lauren A Lau; Chris G Dulla; Barbara J Caldarone; Simon C Robson; Howard L Weiner
Journal:  Immunology       Date:  2017-08-25       Impact factor: 7.397

Review 8.  Sleep and immune function: glial contributions and consequences of aging.

Authors:  Ashley M Ingiosi; Mark R Opp; James M Krueger
Journal:  Curr Opin Neurobiol       Date:  2013-02-26       Impact factor: 6.627

Review 9.  Pannexin-1 Channel Regulates ATP Release in Epilepsy.

Authors:  Yisi Shan; Yaohui Ni; Zhiwei Gao
Journal:  Neurochem Res       Date:  2020-03-13       Impact factor: 3.996

10.  A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes.

Authors:  J Pintor; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.